Placebo Surgery in Clinical Research Trials for Parkinson Disease

被引:0
|
作者
Dunlop, Susan Rebecca [1 ]
McCormick, Margaret [2 ]
机构
[1] Johns Hopkins Parkinsons Dis & Movement Disorders, Baltimore, MD 21287 USA
[2] Towson Univ, Towson, MD USA
来源
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2015年 / 11卷 / 02期
关键词
Belmont Report; Common Rule; deep brain stimulator; equipoise; ethics; fetal tissue transplantation; Parkinson disease; placebo surgery; SHAM SURGERY;
D O I
10.1016/j.nurpra.2014.07.022
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Advances in the field of neurology and neurosurgery have contributed to the development of novel approaches in the treatment of motor symptoms of Parkinson disease (PD). Comparative trials have been performed in PD to evaluate the efficacy of implanted fetal tissue against the standard of care and placebo surgery. Placebo surgery is when a research subject undergoes a surgical procedure that has the appearance of a therapeutic intervention but during which the essential therapeutic maneuver is omitted and is used as the control arm of the research trial. The purpose of this article is to allow nurse practitioners to review the use of placebo surgery as a control arm in the treatment of PD. The potential of transplantation surgeries to improve the lives of those living with neurodegenerative conditions is a fascinating and promising avenue of medical exploration. An overview of clinical trials in which placebo surgery is used as a control is discussed in this article along with the Common Rule and ethical principles to ensure the protection of human subjects in clinical research.
引用
收藏
页码:240 / 247
页数:8
相关论文
共 50 条
  • [1] Placebo effects in Parkinson's disease clinical trials
    Goetz, CG
    Leurgans, S
    Raman, R
    Stebbins, GT
    [J]. NEUROLOGY, 1998, 50 (04) : A71 - A71
  • [2] Placebo surgery in trials of therapy for Parkinson's disease.
    Burris, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (05): : 353 - 353
  • [3] Impact of placebo assignment in clinical trials of Parkinson's disease
    Goetz, CG
    Janko, K
    Blasucci, L
    Jaglin, JA
    [J]. MOVEMENT DISORDERS, 2003, 18 (10) : 1146 - 1149
  • [4] The impact of placebo assignment in clinical trials of Parkinson's disease
    Goetz, CG
    Janko, K
    Blasucci, L
    Jaglin, JA
    [J]. ANNALS OF NEUROLOGY, 2002, 52 (03) : S34 - S34
  • [5] Clinical research coordinator workload in clinical trials in Parkinson's disease
    Dustin, KJ
    Shulman, LM
    [J]. MOVEMENT DISORDERS, 2006, 21 : S121 - S121
  • [6] Predictors of the placebo effect in clinical trials in Parkinson's disease: a meta-analysis
    Shin, C.
    Hahn, S.
    Park, B.
    Kim, J.
    Park, E.
    Jeon, B.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E271 - E272
  • [7] Predictors of the placebo response in clinical trials on Parkinson's disease: A meta-analysis
    Shin, Chae Won
    Hahn, Seokyung
    Park, Byung-Joo
    Kim, Jong-Min
    Park, Eun Ok
    Jeon, Beomseok
    [J]. PARKINSONISM & RELATED DISORDERS, 2016, 29 : 83 - 89
  • [8] Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease
    Freeman, TB
    Vawter, DE
    Leaverton, PE
    Godbold, JH
    Hauser, RA
    Goetz, CG
    Olanow, CW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (13): : 988 - 992
  • [9] Sham surgery controls in Parkinson's disease clinical trials: Views of participants
    Kim, Scott Y. H.
    De Vries, Raymond
    Holloway, Robert G.
    Wilson, Renee
    Parnami, Sonali
    Kim, H. Myra
    Frank, Samuel
    Kieburtz, Karl
    [J]. MOVEMENT DISORDERS, 2012, 27 (11) : 1461 - 1465
  • [10] Factors associated with a placebo effect in Parkinson's disease in clinical trials: a meta-analysis
    Haji, Shotaro
    Sako, Wataru
    Murakami, Nagahisa
    Osaki, Yusuke
    Izumi, Yuishin
    [J]. JOURNAL OF NEUROLOGY, 2024, : 5825 - 5837